Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

RVLP

RVL Pharmaceuticals (RVLP)

RVL Pharmaceuticals PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RVLP
FechaHoraFuenteTítuloSímboloCompañía
17/01/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVLPRVL Pharmaceuticals PLC
27/11/202305:50GlobeNewswire Inc.RVL Completes Financial RestructuringNASDAQ:RVLPRVL Pharmaceuticals PLC
16/11/202308:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
01/11/202315:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVLPRVL Pharmaceuticals PLC
23/10/202315:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
18/10/202315:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RVLPRVL Pharmaceuticals PLC
12/10/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. SubsidiariesNASDAQ:RVLPRVL Pharmaceuticals PLC
05/09/202306:45Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:RVLPRVL Pharmaceuticals PLC
31/08/202313:23Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RVLPRVL Pharmaceuticals PLC
29/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVLPRVL Pharmaceuticals PLC
25/08/202316:21Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RVLPRVL Pharmaceuticals PLC
23/08/202316:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVLPRVL Pharmaceuticals PLC
23/08/202315:05GlobeNewswire Inc.RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:RVLPRVL Pharmaceuticals PLC
17/08/202315:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVLPRVL Pharmaceuticals PLC
16/08/202307:00GlobeNewswire Inc.RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:RVLPRVL Pharmaceuticals PLC
14/08/202308:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVLPRVL Pharmaceuticals PLC
14/08/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business ReviewNASDAQ:RVLPRVL Pharmaceuticals PLC
02/08/202307:30GlobeNewswire Inc.RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial UpdateNASDAQ:RVLPRVL Pharmaceuticals PLC
05/07/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc Provides Business UpdateNASDAQ:RVLPRVL Pharmaceuticals PLC
16/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVLPRVL Pharmaceuticals PLC
15/06/202315:15GlobeNewswire Inc.RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General MeetingNASDAQ:RVLPRVL Pharmaceuticals PLC
11/05/202315:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVLPRVL Pharmaceuticals PLC
11/05/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial UpdateNASDAQ:RVLPRVL Pharmaceuticals PLC
04/05/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial UpdateNASDAQ:RVLPRVL Pharmaceuticals PLC
24/04/202315:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:RVLPRVL Pharmaceuticals PLC
24/04/202315:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RVLPRVL Pharmaceuticals PLC
24/04/202315:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RVLPRVL Pharmaceuticals PLC
03/04/202312:00GlobeNewswire Inc.RVL Pharmaceuticals Announces that Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty AwardsNASDAQ:RVLPRVL Pharmaceuticals PLC
20/03/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Commercial UpdateNASDAQ:RVLPRVL Pharmaceuticals PLC
15/03/202305:50GlobeNewswire Inc.RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Commercial UpdateNASDAQ:RVLPRVL Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:RVLP

Su Consulta Reciente

Delayed Upgrade Clock